A personalized prescription option that may support medical weight management for eligible adults, paired with thoughtful provider guidance and ongoing care.
Tirzepatide is a prescription treatment used within certain medical weight management plans. At Solaié , treatment is never approached as a standard formula. Your provider will carefully consider your medical history, lifestyle and individual goals before discussing whether tirzepatide may be appropriate as part of your personalized care.
Your provider begins by reviewing your health history, current prescriptions, relevant conditions and previous weight-management experience. This helps establish whether tirzepatide may be clinically appropriate.
When prescribed, tirzepatide is administered as a once-weekly injection beneath the skin. Your provider explains the treatment schedule, injection technique and how it fits within your wider wellness plan.
Treatment typically begins at an introductory dose before progressing gradually. Future adjustments are based on the prescribed schedule, tolerability and your provider’s clinical evaluation.
Follow-up appointments allow your provider to review your experience, address possible side effects and consider appropriate adjustments. Nutrition, movement and everyday habits remain an important part of care.
Tirzepatide acts on both GIP and GLP-1 receptors, while semaglutide acts primarily on GLP-1 receptors. The most appropriate option depends on medical eligibility and provider assessment.
FDA-approved tirzepatide for chronic weight management is injected beneath the skin once weekly. Your provider will demonstrate the correct technique and schedule.
Using Zepbound with another tirzepatide-containing product or a GLP-1 receptor agonist is not recommended. All medications must be reviewed before treatment begins.
Commonly reported effects include nausea, diarrhoea, vomiting, constipation, abdominal discomfort, fatigue and injection-site reactions. Your provider will explain potential risks before prescribing.
